###begin article-title 0
Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
###end article-title 0
###begin p 1
###xml 44 77 44 77 <email xmlns:xlink="http://www.w3.org/1999/xlink">karin.jandeleit-dahm@baker.edu.au</email>
Corresponding author: Karin Jandeleit-Dahm, karin.jandeleit-dahm@baker.edu.au
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
###xml 204 208 204 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAGE</italic>
###xml 267 270 267 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
OBJECTIVE-Activation of the receptor for advanced glycation end products (RAGE) in diabetic vasculature is considered to be a key mediator of atherogenesis. This study examines the effects of deletion of RAGE on the development of atherosclerosis in the diabetic apoE-/- model of accelerated atherosclerosis.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 32 35 32 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 44 47 44 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 52 55 52 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
RESEARCH DESIGN AND METHODS-ApoE-/- and RAGE-/-/apoE-/- double knockout mice were rendered diabetic with streptozotocin and followed for 20 weeks, at which time plaque accumulation was assessed by en face analysis.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 30 33 30 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 106 109 104 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 114 117 112 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 247 250 243 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 470 473 460 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p65</italic>
###xml 475 481 465 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VCAM-1</italic>
###xml 487 492 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1</italic>
###xml 625 633 615 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gp91phox</italic>
###xml 635 642 625 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p47phox</italic>
###xml 648 653 638 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rac-1</italic>
###xml 848 851 838 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 950 953 940 943 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 958 961 948 951 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
###xml 251 255 <span type="species:ncbi:10090">mice</span>
###xml 852 856 <span type="species:ncbi:10090">mice</span>
###xml 962 966 <span type="species:ncbi:10090">mice</span>
RESULTS-Although diabetic apoE-/- mice showed increased plaque accumulation (14.9 +/- 1.7%), diabetic RAGE-/-/apoE-/- mice had significantly reduced atherosclerotic plaque area (4.9 +/- 0.4%) to levels not significantly different from control apoE-/- mice (4.3 +/- 0.4%). These beneficial effects on the vasculature were associated with attenuation of leukocyte recruitment; decreased expression of proinflammatory mediators, including the nuclear factor-kappaB subunit p65, VCAM-1, and MCP-1; and reduced oxidative stress, as reflected by staining for nitrotyrosine and reduced expression of various NADPH oxidase subunits, gp91phox, p47phox, and rac-1. Both RAGE and RAGE ligands, including S100A8/A9, high mobility group box 1 (HMGB1), and the advanced glycation end product (AGE) carboxymethyllysine were increased in plaques from diabetic apoE-/- mice. Furthermore, the accumulation of AGEs and other ligands to RAGE was reduced in diabetic RAGE-/-/apoE-/- mice.
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
CONCLUSIONS-This study provides evidence for RAGE playing a central role in the development of accelerated atherosclerosis associated with diabetes. These findings emphasize the potential utility of strategies targeting RAGE activation in the prevention and treatment of diabetic macrovascular complications.
###end p 6
###begin p 7
Published ahead of print at  on 28 May 2008.
###end p 7
###begin p 8
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 8
###begin p 9
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 422 423 422 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 456 459 456 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 520 521 520 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 522 523 522 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 558 559 558 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 928 929 928 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 930 931 930 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 1170 1172 1170 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 1173 1175 1173 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 1182 1185 1182 1185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1307 1309 1307 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 1453 1454 1453 1454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 1455 1456 1455 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 1478 1479 1478 1479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 1801 1804 1793 1796 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1809 1812 1801 1804 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 228 234 <span type="species:ncbi:9606">humans</span>
###xml 460 464 <span type="species:ncbi:10090">mice</span>
###xml 552 556 <span type="species:ncbi:10090">mice</span>
###xml 1186 1190 <span type="species:ncbi:10090">mice</span>
###xml 1493 1497 <span type="species:ncbi:10090">mice</span>
###xml 1813 1818 <span type="species:ncbi:10090">mouse</span>
###xml 2197 2201 <span type="species:ncbi:10090">mice</span>
The receptor for advanced glycation end products (RAGE) is a multiligand cell surface molecule belonging to the immunoglobulin superfamily (1). It is expressed as full-length, N-truncated, and C-truncated isoforms, generated in humans by alternative splicing (2). Activation of the full-length RAGE receptor has been implicated in a range of chronic diseases, including various diabetic complications and atherosclerosis (1). In particular, studies in RAGE-/- mice that carry the dominant-negative form of the receptor (2-6) and in RAGE-overexpressing mice (7) have confirmed an important role of RAGE activation in the development of diabetic nephropathy, neuropathy, and impaired angiogenesis. RAGE activation has also been implicated in the acceleration of atherosclerotic lesion formation as well as in the maintenance of proinflammatory and prothrombotic mechanisms, characteristic of diabetes-accelerated atherosclerosis (8,9). RAGE also represents an important mediator of oxidative stress in diabetes. Activation of RAGE in vitro leads to increased NADPH oxidase expression, mitochondrial oxidase activity, and downregulation of endogenous antioxidant activity (10,11). RAGE-/- mice have a suppression of neointimal proliferation after externally induced arterial injury in the absence of diabetes (12). Moreover, blockade of RAGE-dependent signaling by soluble RAGE (sRAGE) has been shown to inhibit the progression of atherosclerotic changes (8,9) and kidney disease (3) in diabetic mice, possibly by suppressing the activation of nuclear factor-kappaB (NF-kappaB) activation and inflammatory cytokine expression. The present study examined the role of RAGE in the development of diabetes-accelerated atherosclerosis in a model of insulin deficiency, the streptozotocin-induced diabetic RAGE-/-/apoE-/- mouse. Our aim was to determine the effect of global RAGE deficiency, which includes absence of both the full-length receptor and endogenous sRAGE on the development of vascular lesions in the presence and absence of diabetes. Furthermore, key mediators of the atherosclerotic process in diabetes were examined, and the effects on these pathways were assessed in these RAGE-deficient mice.
###end p 9
###begin title 10
RESEARCH DESIGN AND METHODS
###end title 10
###begin p 11
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 224 225 224 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 256 259 256 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 377 380 377 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 385 388 385 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 425 428 425 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 474 477 474 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 806 807 806 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 986 988 986 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 1328 1329 1328 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1507 1508 1507 1508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1711 1713 1705 1707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 201 206 <span type="species:ncbi:9606">human</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 429 433 <span type="species:ncbi:10090">mice</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
###xml 800 804 <span type="species:ncbi:10090">Mice</span>
###xml 1088 1092 <span type="species:ncbi:10090">Mice</span>
###xml 1125 1130 <span type="species:ncbi:10090">mouse</span>
###xml 1158 1162 <span type="species:ncbi:10090">Mice</span>
###xml 1501 1505 <span type="species:ncbi:10090">mice</span>
###xml 1801 1805 <span type="species:ncbi:10090">mice</span>
This study used the well-characterized apoE-/- mouse model of accelerated atherosclerosis, whereby mice develop complex vascular lesions after 20 weeks of diabetes that resemble the morphology seen in human atherosclerosis (9,13-15). Six-week-old male apoE-/- mice (backcrossed 20 times to a C57BL/6 background; Animal Resource Centre, Canning Vale, Western Australia) and RAGE-/-/apoE-/- mice, generated by backcrossing RAGE-/- mice (16) on the C57BL/6 background into apoE-/- mice on the same background for 10 generations (University of Heidelberg, Heidelberg, Germany) (Supplementary Fig. 1, available in an online appendix at ), were housed at the Precinct Animal Centre at Baker Heart Research Institute and studied according to National Health and Medical Research Council (NHMRC) guidelines. Mice (n = 24/group) were rendered diabetic via five daily intraperitoneal injections of 55 mg/kg streptozotocin (Boehringer, Mannheim, Germany) per day, resulting in insulin deficiency (13). Control animals received vehicle (citrate buffer) alone. All animals were followed for 20 weeks. Mice were allowed access to standard mouse chow and water ad libitum. Mice were killed using an intraperitoneal injection of 100 mg/kg Euthal (Delvet, Seven Hills, Australia), followed by exsanguination by cardiac puncture. Excised aortas (n = 10-14) were placed in 10% neutral buffered formalin and quantitated for lesion area before being embedded in paraffin for immunohistochemical analysis. In the remaining mice (n = 10-14), aortas were snap-frozen in liquid nitrogen and stored at -70degreesC for subsequent RNA extraction. At the conclusion of the study, GHb was measured by high-performance liquid chromatography (17). Total plasma cholesterol, HDL, and triglyceride concentrations were measured in 9-10 mice per group by autoanalyzer. LDL cholesterol was calculated by the Friedewald formula. The S100 A8/A9 ELISA kit (Immundiagnostik, Bensheim, Germany) was used to measure this S100 isoform in plasma according to the manufacturer's instructions. A Quantitative ELISA (Shino-Test, Tokyo) was used to measure plasma high mobility group box 1 (HMGB1) concentration.
###end p 11
###begin title 12
Plaque area quantitation.
###end title 12
###begin p 13
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 56 58 56 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 79 80 79 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
Plaque area was quantitated as described previously (13,15). In brief, aortas (n = 10-14 aortas/group) were cleaned of excess fat under a dissecting microscope and subsequently stained with Sudan IV-Herxheimer's solution (0.5% wt/vol) (Gurr; BDH, Poole, U.K.). Aortas were dissected longitudinally; divided into arch, thoracic, and abdominal segments; and pinned flat onto wax. Images were acquired with a dissecting microscope equipped with an Axiocam camera (Zeiss, Heidelberg, Germany). Total and segmental plaque area was quantitated as a percentage area of aorta stained (Adobe Photoshop version 7.0). Tissue was subsequently embedded in paraffin, and sections were cut for immunohistochemical analysis.
###end p 13
###begin title 14
Real-time RT-PCR.
###end title 14
###begin p 15
###xml 97 104 <span type="species:ncbi:3879">Lucerne</span>
Total RNA was extracted from whole aorta by homogenizing (Polytron PT-MR2100; Kinematica, Littau-Lucerne, Switzerland) in TRIzol (Life Technologies, Rockville, MD). Total RNA was then DNase-treated (DNA removal kit; Ambion, Austin, TX), and cDNA was synthesized by reverse transcription (Pierce Biotechnology, Rockford, IL). Quantitative real-time RT-PCR was performed using the Taqman System on an ABI Prism 7500 Sequence Detector (Applied Biosystems, Foster City, CA) and analyzed using software detection systems (SDS version 1.9) software. Gene expression was normalized to 18S rRNA (Applied Biosystems). Detailed information on probes is provided in Supplementary Table 1. For each analysis, 10-14 animals per group were used.
###end p 15
###begin title 16
Immunohistochemistry.
###end title 16
###begin p 17
###xml 404 408 <span type="species:ncbi:9925">goat</span>
###xml 414 419 <span type="species:ncbi:9606">human</span>
###xml 1014 1019 <span type="species:ncbi:10090">mouse</span>
###xml 1068 1071 <span type="species:ncbi:10116">rat</span>
###xml 1115 1121 <span type="species:ncbi:9986">rabbit</span>
###xml 1157 1161 <span type="species:ncbi:9925">goat</span>
Serial 4-mum sections were stained for alpha-smooth muscle actin (alpha-SMA) (1:200; DakoCytomation, Carpinteria, CA), the macrophage marker F4/80 (1:50; Serotec, Oxford, U.K.), nitrotyrosine (1:50; Chemicon, Temecula, CA), S100A8/A9 (1:250; Immundiagnostik), HMGB1 (1:1,000; Abcam, Cambridge, U.K.), carboxymethyllysine (CML) (1:1,000; Abcam), the T-cell marker CD3 (1:50; Abcam), collagens III and IV (goat anti-human collagen III and IV; 1:75 and 1:800, respectively; SouthernBiotech, Birmingham, AL), vascular cell adhesion molecule-1 (VCAM-1) (1:50; Pharmingen, San Diego, CA), and monocyte chemotactic protein-1 (MCP-1) (1:500; R&D Systems, Minneapolis, MN). Enzymatic trypsin antigen retrieval was used for F4/80, pepsin digestion in 0.01 mol/l HCl was used for collagen III and IV, and heat-induced antigen retrieval in 0.01 mol/l citric acid (pH 6.0) was applied for HMGB1 and CD3 antibodies. Sections were incubated with the primary antibody overnight at 4degreesC. Secondary antibody, biotinylated anti-mouse IgG (Vector Laboratories, Burlingame, CA), anti-rat immunoglobulin (Vector Laboratories), anti-rabbit IgG (Vector Laboratories), or anti-goat IgG (Vector Laboratories) were added 1:200 to 1:500 to sections for 30 min at room temperature. This was followed by Vectastain ABC Elite reagent (Vector Laboratories) or alternatively catalyzed signal amplification (DakoCytomation). Peroxidase activity was identified by reaction with 3,3'-diaminobenzidine tetrahydrochloride (Sigma-Aldrich, St. Louis, MO) or 3-amino-9-ethylcarbazole (Vector Laboratories) substrate. Sections were counterstained with Mayer's hematoxylin when appropriate. Staining was quantitated from digital microscope photographs as percent of positively stained tissue using ImagePro 6.0 software. For each analysis, 7-10 animals per group were used.
###end p 17
###begin title 18
Western blotting.
###end title 18
###begin p 19
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
###xml 157 162 <span type="species:ncbi:10090">mouse</span>
###xml 223 228 <span type="species:ncbi:10090">mouse</span>
###xml 415 420 <span type="species:ncbi:10090">mouse</span>
Total lysates from mouse aorta were subjected to 10-12% SDS-PAGE and transferred onto polyvinylidene difluoride membranes. The membranes were incubated with mouse monoclonal anti-MCP-1 antibody (R&D Systems) at 1 mug/ml or mouse monoclonal anti-beta-actin (Abcam) at 1/10,000 dilution. The membranes were washed with Tris-buffered saline with Tween and then incubated with EnVision+ System-HRP-Labeled Polymer anti-mouse secondary antibody at 1/25 (DakoCytomation). Immunoreactivity was detected using an enhanced chemiluminescence kit (Sigma-Aldrich).
###end p 19
###begin title 20
Statistical analysis.
###end title 20
###begin p 21
###xml 224 225 222 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Data were analyzed by ANOVA using SPSS 15.0 software. Post hoc comparisons were made among the various groups using Fishers least significant difference method. Data are expressed as means +/- SE unless otherwise specified. P < 0.05 was considered to be statistically significant.
###end p 21
###begin title 22
RESULTS
###end title 22
###begin title 23
Metabolic parameters.
###end title 23
###begin p 24
###xml 38 41 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 179 186 179 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 378 381 378 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 386 389 386 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 390 394 <span type="species:ncbi:10090">mice</span>
The induction of diabetes in both RAGE-/-/apoE-/- and apoE-/- mice resulted in increased plasma glucose and GHb concentrations, which were comparable between the diabetic groups (Table 1). Plasma concentrations of total and LDL cholesterol levels were also significantly increased in both groups following the induction of diabetes, although this increase was attenuated in RAGE-/-/apoE-/- mice.
###end p 24
###begin title 25
Plaque accumulation.
###end title 25
###begin p 26
###xml 33 36 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 234 237 234 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 242 245 242 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 335 338 335 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 351 352 351 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 345 352 345 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 412 415 412 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 420 423 420 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 588 591 588 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 596 599 596 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 636 639 636 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 652 653 652 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 658 659 658 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 646 659 646 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic> and <italic>B</italic></xref>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
###xml 424 428 <span type="species:ncbi:10090">mice</span>
###xml 600 604 <span type="species:ncbi:10090">mice</span>
###xml 640 644 <span type="species:ncbi:10090">mice</span>
The induction of diabetes in apoE-/- mice led to a significant (approximately fourfold) increase in total atherosclerotic plaque area. However, this diabetes-associated increase in plaque area was completely prevented in diabetic RAGE-/-/apoE-/- mice, with plaque accumulation not significantly different from that seen in control apoE-/- mice (Fig. 1A). The reduction in the plaque accumulation in diabetic RAGE-/-/apoE-/- mice was observed at all three aortic sites: the arch, thoracic, and abdominal aortas. In addition, there was a further reduction in plaque area in nondiabetic RAGE-/-/apoE-/- mice when compared with control apoE-/- mice (Fig. 1A and B).
###end p 26
###begin title 27
Plaque morphology and smooth muscle cell recruitment.
###end title 27
###begin p 28
###xml 339 342 339 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 544 547 540 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 629 632 625 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 637 640 633 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 744 747 736 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 272 277 <span type="species:ncbi:9606">human</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 548 552 <span type="species:ncbi:10090">mice</span>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
###xml 748 752 <span type="species:ncbi:10090">mice</span>
The induction of diabetes was not only associated with plaque accumulation, but, in addition, diabetic plaque was also significantly more complex, characterized by increased accumulation of foam cells, cholesterol clefts, and leukocyte recruitment similar to that seen in human disease. Furthermore, atherosclerotic plaque in diabetic apoE-/- mice involves the proliferation and migration of medial vascular smooth muscle cells into the vessel intima, as demonstrated by increased expression of alpha-SMA protein when compared with control apoE-/- mice (Supplementary Fig. 2). However, the atherosclerotic plaque in diabetic RAGE-/-/apoE-/- mice was significantly less complex, with reduced alpha-SMA expression when compared with diabetic apoE-/- mice.
###end p 28
###begin title 29
Vascular accumulation of macrophages and T-cells.
###end title 29
###begin p 30
###xml 171 174 171 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 228 229 228 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 234 235 234 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 222 235 222 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic> and <italic>B</italic></xref>
###xml 321 324 321 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 329 332 329 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 393 396 393 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 420 423 420 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 428 431 428 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 628 631 628 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 667 668 667 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 673 674 673 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 661 674 661 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic> and <italic>D</italic></xref>
###xml 738 741 738 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 746 749 746 749 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 787 790 787 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 937 940 937 940 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 632 636 <span type="species:ncbi:10090">mice</span>
###xml 750 754 <span type="species:ncbi:10090">mice</span>
###xml 791 795 <span type="species:ncbi:10090">mice</span>
###xml 941 945 <span type="species:ncbi:10090">mice</span>
Leukocyte recruitment is a key component of vascular inflammation and atherogenesis. In our study, there was increased CD3 staining in the vessel wall of the diabetic apoE-/- mice, consistent with accumulation of T-cells (Fig. 2A and B). T-cell recruitment associated with diabetes was significantly decreased in the RAGE-/-/apoE-/- mice to levels not significantly different from control apoE-/- mice, with control RAGE-/-/apoE-/- mice showing an additional reduction in vascular T-cell recruitment. Similarly, macrophage accumulation, as detected by staining with the F4/80 marker, was significantly increased in diabetic apoE-/- mice compared with controls (Fig. 2C and D). Macrophage accumulation was also reduced in the diabetic RAGE-/-/apoE-/- mice when compared with diabetic apoE-/- mice. Macrophage staining was detected in both the vascular wall and the fibrous cap of the atherosclerotic lesions, particularly in diabetic apoE-/- mice.
###end p 30
###begin title 31
Markers of vascular inflammation.
###end title 31
###begin p 32
###xml 215 216 215 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 400 403 400 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 519 522 515 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p65</italic>
###xml 524 529 520 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1</italic>
###xml 531 537 527 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VCAM-1</italic>
###xml 539 552 535 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tissue factor</italic>
###xml 627 631 623 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rac1</italic>
###xml 634 641 630 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 676 679 672 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 684 687 680 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 850 853 846 849 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 862 869 858 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 961 964 957 960 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1106 1109 1102 1105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1114 1117 1110 1113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1144 1145 1140 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1150 1151 1146 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1285 1288 1281 1284 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1383 1386 1379 1382 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1391 1394 1387 1390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1416 1417 1412 1413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1509 1512 1505 1508 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1645 1648 1641 1644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1682 1685 1678 1681 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1690 1693 1686 1689 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 341 346 <span type="species:ncbi:9606">human</span>
###xml 404 408 <span type="species:ncbi:10090">mice</span>
###xml 688 692 <span type="species:ncbi:10090">mice</span>
###xml 965 969 <span type="species:ncbi:10090">mice</span>
###xml 1118 1122 <span type="species:ncbi:10090">mice</span>
###xml 1289 1293 <span type="species:ncbi:10090">mice</span>
###xml 1513 1517 <span type="species:ncbi:10090">mice</span>
###xml 1649 1653 <span type="species:ncbi:10090">mice</span>
###xml 1694 1698 <span type="species:ncbi:10090">mice</span>
To explore the potential mechanisms responsible for vascular protection in our model, we studied the aortic gene transcription of various proteins that have previously been linked to generation of vascular lesions (9,18,19). In particular, vascular inflammation is thought to be the key initiator of atherosclerosis in both experimental and human disease. Accelerated atherosclerosis in diabetic apoE-/- mice was associated with increased aortic expression of the proinflammatory transcription factor NF-kappaB subunit p65, MCP-1, VCAM-1, tissue factor, and the renin-angiotensin system (RAS)-related C3 botulinum substrate 1 (rac1) (Table 2). Reduction in plaque area in RAGE-/-/apoE-/- mice was also associated with a significant reduction in gene expression of these proatherosclerotic mediators to levels similar to those observed in control apoE-/- aortas (Table 2). By immunohistochemistry, MCP-1 expression was increased at least twofold in diabetic apoE-/- mice particularly within the plaque, specifically foam cells and macrophages, and this increase was not seen in the aortas from diabetic RAGE-/-/apoE-/- mice (Supplementary Fig. 3A and B). In addition, Western blot analysis showed that MCP-1 protein expression was increased twofold in aortic extracts from diabetic apoE-/- mice, and this increased expression was significantly reduced in the aortas from diabetic RAGE-/-/apoE-/- (Supplementary Fig. 3C). Aortic VCAM-1 protein expression was also assessed by immunohistochemistry. Diabetic apoE-/- mice had significantly increased vascular VCAM-1 staining, including within endothelial cells, and this was not seen in control apoE-/- mice or diabetic and control RAGE-/-/apoE-/- mice (Supplementary Fig. 4).
###end p 32
###begin title 33
Expression of collagens and matrix metalloproteinases.
###end title 33
###begin p 34
###xml 19 29 19 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">collagen I</italic>
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">III</italic>
###xml 36 38 36 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IV</italic>
###xml 46 47 42 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 54 56 50 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IV</italic>
###xml 62 65 54 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">III</italic>
###xml 101 104 93 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 141 144 133 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 152 159 144 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 239 242 231 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 247 250 239 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 289 292 281 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 502 505 494 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 615 618 607 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 672 675 664 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 680 683 672 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
###xml 506 510 <span type="species:ncbi:10090">mice</span>
###xml 619 623 <span type="species:ncbi:10090">mice</span>
###xml 684 688 <span type="species:ncbi:10090">mice</span>
Gene expression of collagen I, III, IV (alpha I), and IValpha III were increased in the diabetic apoE-/- aorta compared with the control apoE-/- aorta (Table 2). Collagen III gene expression was significantly decreased in the diabetic RAGE-/-/apoE-/- aorta when compared with diabetic apoE-/- mice. We also assessed collagen protein expression in the vascular wall by immunohistochemistry, specifically assessing the fibrillar type III collagen and the basement membrane type IV collagen. Diabetic apoE-/- mice have significantly increased vascular collagen III and collagen IV deposition compared with control apoE-/- mice (Supplementary Figs. 5 and 6). The diabetic RAGE-/-/apoE-/- mice had significantly less collagen III and IV staining.
###end p 34
###begin p 35
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP-2</italic>
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP-9</italic>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 240 245 240 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP-2</italic>
###xml 291 296 291 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP-9</italic>
###xml 317 320 317 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 357 360 357 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 368 373 368 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP-9</italic>
###xml 435 438 435 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 443 446 443 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 462 467 462 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP-2</italic>
###xml 525 528 525 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
We also examined the gene expression of matrix metalloproteinases 2 and 9 (MMP-2 and MMP-9, respectively) that are involved in the inflammatory response and in collagen degradation (20). There was a threefold induction in the expression of MMP-2 and a twofold induction in the expression of MMP-9 in the diabetic apoE-/- aorta compared with the control apoE-/- aorta. MMP-9 gene expression was significantly attenuated in diabetic RAGE-/-/apoE-/- aorta, whereas MMP-2 gene expression was similar to that seen in diabetic apoE-/- aorta.
###end p 35
###begin title 36
Accumulation of RAGE ligands.
###end title 36
###begin p 37
###xml 241 244 241 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 344 347 344 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 420 426 420 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3</xref>
###xml 490 493 490 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 498 501 498 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 638 639 638 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 684 687 684 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 729 732 729 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 765 768 765 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 773 776 773 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 783 789 783 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4</xref>
###xml 901 904 901 904 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 909 912 909 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 945 948 945 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 988 989 984 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1015 1018 1011 1014 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1023 1026 1019 1022 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1109 1112 1105 1108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1152 1153 1144 1145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 502 506 <span type="species:ncbi:10090">mice</span>
###xml 733 737 <span type="species:ncbi:10090">mice</span>
###xml 777 781 <span type="species:ncbi:10090">mice</span>
###xml 913 917 <span type="species:ncbi:10090">mice</span>
###xml 949 953 <span type="species:ncbi:10090">mice</span>
###xml 1027 1031 <span type="species:ncbi:10090">mice</span>
###xml 1113 1117 <span type="species:ncbi:10090">mice</span>
The accumulation of a range of RAGE ligands, including the advanced glycation end product (AGE), CML, HMGB1, and S100A8/A9, in settings such as diabetes are considered to play a role in progressive vascular injury. As expected, diabetic apoE-/- mice had a significant elevation in vascular AGE deposition when compared with the nondiabetic apoE-/- animals, as detected by immunostaining for the well-described AGE, CML (Fig. 3). CML immunostaining was reduced in the aortas of diabetic RAGE-/-/apoE-/- mice to levels not significantly different from control animals. A similar pattern was seen with respect to another RAGE ligand, HMGB1 (1), with increased expression in diabetic apoE-/- aorta when compared with the control apoE-/- mice, with normalization in RAGE-/-/apoE-/- mice (Fig. 4). We also measured plasma HMGB1 concentrations. Interestingly, plasma HMGB1 levels were higher in diabetic RAGE-/-/apoE-/- mice compared with diabetic apoE-/- mice (369 +/- 44 vs. 201 +/- 13 ng/ml, P < 0.05). Nondiabetic RAGE-/-/apoE-/- mice tended to have slightly higher circulating HMGB1 levels than nondiabetic apoE-/- mice (356 +/- 63 vs. 235 +/- 28 ng/ml, P = 0.11).
###end p 37
###begin p 38
###xml 17 20 17 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 183 184 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 189 190 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 177 190 177 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>A</italic> and <italic>B</italic></xref>
###xml 329 332 329 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 337 340 337 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 450 453 450 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 479 482 479 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 598 599 598 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 592 599 592 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>C</italic></xref>
###xml 613 616 613 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 621 624 621 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 341 345 <span type="species:ncbi:10090">mice</span>
###xml 483 487 <span type="species:ncbi:10090">mice</span>
###xml 625 629 <span type="species:ncbi:10090">mice</span>
###xml 686 690 <span type="species:ncbi:10090">mice</span>
The diabetic apoE-/- mice had significantly increased positive staining of the proinflammatory cytokine, S100A8/A9, a known RAGE ligand (21) when compared with control animals (Fig. 5A and B), with prominent staining appearing in the aortic lesions, particularly within macrophages, foam cells, and endothelial cells. In the RAGE-/-/apoE-/- mice, the aortic expression of S100A8/A9 protein was significantly decreased when compared with diabetic apoE-/- aortas. The diabetic apoE-/- mice also had a significant elevation in circulating levels of S100A8/A9 when compared with control animals (Fig. 5C). In the RAGE-/-/apoE-/- mice, S100A8/A9 levels were similar to those seen in control mice.
###end p 38
###begin title 39
Expression of AGE receptors.
###end title 39
###begin p 40
###xml 25 27 25 27 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 28 30 28 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 75 78 75 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 145 152 145 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 241 245 241 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAGE</italic>
###xml 264 267 264 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 272 275 272 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 393 399 393 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGE-R1</italic>
###xml 433 439 433 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGE-R3</italic>
###xml 500 504 500 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD36</italic>
###xml 522 525 522 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 530 533 530 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 629 636 629 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
As previously described (14,15), the expression of full-length RAGE in apoE-/- mice was significantly increased after the induction of diabetes (Table 2), with focal expression overlying atherosclerotic plaque (data not shown). There was no RAGE expression in RAGE-/-/apoE-/- aorta. The induction of diabetes was also associated with increased expression of AGE clearance receptors, including AGE-R1 (oligosaccharyl transferase-48), AGE-R3 (galectin-3), and the type B macrophage scavenger receptor, CD36. However, in RAGE-/-/apoE-/- mice, the increased gene expression of these other AGE receptors was significantly attenuated (Table 2).
###end p 40
###begin title 41
NADPH oxidase and oxidative stress in the vascular wall.
###end title 41
###begin p 42
###xml 206 213 206 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p47phox</italic>
###xml 241 249 241 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gp91phox</italic>
###xml 272 275 272 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 307 310 307 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 315 318 315 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 401 408 401 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 424 427 424 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 560 566 560 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6</xref>
###xml 650 653 650 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 658 661 658 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 662 666 <span type="species:ncbi:10090">mice</span>
We determined the potential impact of RAGE on the superoxide-generating NADPH oxidase in the diabetic vasculature. Interestingly, diabetes induced a 5.3-fold increase in expression of NADPH oxidase subunit p47phox and a 3.5-fold increase in gp91phox expression in the apoE-/- aorta, whereas in diabetic RAGE-/-/apoE-/- double knockout mice, this upregulation of NADPH oxidase subunits was attenuated (Table 2). Diabetic apoE-/- mice also had increased expression of nitrotyrosine in their aortas, suggesting increased peroxynitrite-mediated protein oxidation (Fig. 6). Diabetes did not lead to a similar increase in nitrotyrosine staining in the RAGE-/-/apoE-/- mice.
###end p 42
###begin title 43
AT1 receptor expression.
###end title 43
###begin p 44
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 151 154 151 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 241 245 241 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AT1a</italic>
###xml 255 259 255 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AT1a</italic>
###xml 318 321 318 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 326 329 326 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 367 370 367 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 377 384 377 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
Reflecting an activated vascular RAS, which is known to upregulate NADPH-oxidase-dependent reactive oxygen species (ROS) generation (22), diabetic apoE-/- mice had a marked increase in gene expression of the angiotensin II type 1a receptor (AT1a). Aortic AT1a gene expression was significantly reduced in diabetic RAGE-/-/apoE-/- mice when compared with diabetic apoE-/- mice (Table 2).
###end p 44
###begin title 45
DISCUSSION
###end title 45
###begin p 46
###xml 495 498 495 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 562 566 562 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAGE</italic>
###xml 701 704 701 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 976 978 976 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 979 981 979 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 982 984 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 1117 1120 1117 1120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1125 1128 1125 1128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1307 1310 1307 1310 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1381 1384 1381 1384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1389 1392 1389 1392 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1466 1469 1466 1469 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1480 1483 1480 1483 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1571 1573 1571 1573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 1714 1716 1714 1716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 499 504 <span type="species:ncbi:10090">mouse</span>
###xml 705 709 <span type="species:ncbi:10090">mice</span>
###xml 750 758 <span type="species:ncbi:9606">patients</span>
###xml 1145 1149 <span type="species:ncbi:10090">mice</span>
###xml 1311 1315 <span type="species:ncbi:10090">mice</span>
###xml 1393 1397 <span type="species:ncbi:10090">mice</span>
###xml 1470 1474 <span type="species:ncbi:10090">mice</span>
###xml 1484 1488 <span type="species:ncbi:10090">mice</span>
###xml 1633 1637 <span type="species:ncbi:10090">mice</span>
Atherosclerotic vascular disease is a major cause of morbidity and mortality in the diabetic population with accelerated plaque accumulation and vascular inflammation. Although a number of mechanisms have been postulated to contribute to the development and progression of atherosclerotic disease in diabetes, in the present study, we provide evidence that RAGE-dependent pathways play a central role in promoting vascular lesions in a rodent model of advanced atherosclerosis, the diabetic apoE-/- mouse. Our results show for the first time that the absence of RAGE suppresses diabetes-accelerated atherosclerosis. Our group has previously shown that the atherosclerotic plaques seen in diabetic apoE-/- mice resemble the complex morphology seen in patients with diabetes, including enhanced accumulation of macrophages, foam cells, and cholesterol clefts within the fatty atheroma and increased expression of inflammatory markers, proinflammatory cytokines, and chemokines (14,15,18). Without normalizing glucose or lipid levels, we show that in the absence of both full-length and sRAGE expression in diabetic RAGE-/-/apoE-/- double knockout mice, the extent of plaque accumulation, vascular inflammation, and oxidative stress was significantly reduced to levels similar to those observed in control apoE-/- mice. In addition, atherosclerosis was further reduced in control RAGE-/-/apoE-/- mice. These data are consistent with previous studies in nondiabetic RAGE-/- mice. RAGE-/- mice demonstrated suppression of neointimal expansion after femoral artery denudation (12). Furthermore, a recent study in apoE/RAGE double knockout mice has also demonstrated reduced plaque area, albeit in a nondiabetic context (23).
###end p 46
###begin p 47
###xml 38 39 38 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 266 268 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 269 271 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 272 274 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 571 573 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 691 694 688 691 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 771 774 768 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 779 782 776 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 950 953 947 950 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 958 961 955 958 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1010 1016 1007 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGE-R1</italic>
###xml 1018 1023 1015 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OST-3</italic>
###xml 1029 1035 1026 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGE-R3</italic>
###xml 1037 1047 1034 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">galactin-3</italic>
###xml 1095 1098 1092 1095 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1103 1106 1100 1103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1231 1235 1228 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD36</italic>
###xml 1237 1239 1234 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 1277 1280 1274 1277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1285 1288 1282 1285 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1532 1534 1529 1531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 695 699 <span type="species:ncbi:10090">mice</span>
###xml 783 787 <span type="species:ncbi:10090">mice</span>
###xml 962 966 <span type="species:ncbi:10090">mice</span>
###xml 1107 1111 <span type="species:ncbi:10090">mice</span>
###xml 1289 1293 <span type="species:ncbi:10090">mice</span>
###xml 1526 1530 <span type="species:ncbi:10090">mice</span>
RAGE is pattern recognition receptor (1) that is able to bind a chemically diverse range of AGEs and other non-AGE ligands, including s100/calgranulins, HMGB1, and beta-sheet fibrils. In atherosclerotic vascular disease, the expression of RAGE is focally increased (14,15,21), paralleling an accumulation in RAGE ligands. The major RAGE ligand in the context of diabetes remains to be established. However, the efficacy of AGE-reducing interventions, including alagebrium and aminoguanidine, on diabetes-associated atherosclerosis suggests that AGEs play a pivotal role (14). In this study, we demonstrate increased vascular accumulation of CML along with other RAGE ligands in diabetic apoE-/- mice. This increase in vascular CML was markedly attenuated in diabetic RAGE-/-/apoE-/- mice, although the hyperglycemia and hyperlipidemia were not corrected. This decrease in vascular AGEs was not due to overexpression of AGE clearance receptors in RAGE-/-/apoE-/- mice. In fact, diabetes-associated increases in AGE-R1 (OST-3) and AGE-R3 (galactin-3) were significantly attenuated in diabetic RAGE-/-/apoE-/- mice, possibly reflecting reduced AGE accumulation in these animals. Expression of the type B macrophage scavenger receptor CD36 (24) was also attenuated in diabetic RAGE-/-/apoE-/- mice. Although this change is likely to be secondary to reduced leukocyte recruitment, CD36 has been clearly demonstrated to play a proatherogenic role because the absence of macrophage CD36 protects against vascular lesion formation in mice (25). Thus, one cannot exclude that some of the antiatherosclerotic effects seen with RAGE deletion could be related to changes in the expression of CD36.
###end p 47
###begin p 48
###xml 40 43 40 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 307 310 307 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 394 397 394 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 402 405 402 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 831 838 831 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p47phox</italic>
###xml 843 851 843 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gp91phox</italic>
###xml 884 888 884 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rac1</italic>
###xml 1050 1053 1050 1053 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1058 1061 1058 1061 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1186 1188 1186 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 1221 1224 1221 1224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1280 1283 1280 1283 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1288 1291 1288 1291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
###xml 1062 1066 <span type="species:ncbi:10090">mice</span>
###xml 1225 1229 <span type="species:ncbi:10090">mice</span>
###xml 1292 1296 <span type="species:ncbi:10090">mice</span>
Plaque accumulation in the diabetic apoE-/- mouse is closely correlated with the generation of ROS, which drive a number of proatherogenic processes, such as monocyte infiltration, smooth muscle cell recruitment, cell adhesion, and increased accumulation of AGEs, which are all observed in the diabetic apoE-/- plaque. For example, we have recently shown that increased oxidative stress in GPx1-/-/apoE-/- mice accelerates diabetes-associated atherosclerosis via upregulation of proinflammatory and profibrotic pathways (26). The role of RAGE as a mediator of oxidative stress in diabetes was also observed in the present study. In our study, diabetes was associated with increases in vascular oxidative stress, as demonstrated by aortic nitrotyrosine staining. This probably occurred partly as a result of increased expression of p47phox and gp91phox, subunits of NAPDH oxidase, and rac1, a GTPase involved in NADPH oxidase activation. Expression of the NADPH subunits as well as nitrotyrosine staining were significantly attenuated in diabetic RAGE-/-/apoE-/- mice. Furthermore, aortic gene expression of the AT1a receptor, which is known to enhance ROS generation via NADPH oxidase (27), was increased in diabetic apoE-/- mice yet was significantly reduced in the diabetic RAGE-/-/apoE-/- mice.
###end p 48
###begin p 49
###xml 491 494 491 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 499 502 499 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1086 1088 1070 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 1263 1265 1247 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 1362 1365 1342 1345 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1535 1538 1507 1510 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1543 1546 1515 1518 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1670 1675 1634 1639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1</italic>
###xml 1677 1682 1641 1646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MCP-1</italic>
###xml 1750 1753 1714 1717 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1818 1821 1782 1785 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1826 1829 1790 1793 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 503 507 <span type="species:ncbi:10090">mice</span>
###xml 1547 1551 <span type="species:ncbi:10090">mice</span>
###xml 1754 1758 <span type="species:ncbi:10090">mice</span>
###xml 1830 1834 <span type="species:ncbi:10090">mice</span>
RAGE activation is involved not only in the acceleration of atherosclerotic lesion formation but also in promoting proinflammatory pathways considered to play an important role in diabetes-accelerated atherosclerosis. For example, the diabetic plaque is characterized by the increased expression of inflammatory cytokines, chemokines and adhesion molecules that promote leukocyte infiltration and foam cell accumulation. This inflammatory response was clearly attenuated in the diabetic RAGE-/-/apoE-/- mice, as reflected by decreased accumulation of macrophages and T-cells and reduced aortic expression of related chemokines, cytokines, and adhesion molecules. A number of different components contribute to RAGE-induced inflammation, including oxidative stress and AGE accumulation. However, one key mediator appears to be activation of the proinflammatory transcription factor NF-kappaB, because RAGE has the unique ability to sustain NF-kappaB activation through de novo synthesis of NF-kappaB p65-mRNA and to provide a constantly growing pool of transcriptional active NF-kappaB (28). The downstream effects of this pathway include activation of NADPH oxidase, VCAM-1, and tissue factor and the autoinduction of RAGE expression in a positive feedback loop (29). In our study, the expression of the NF-kappaB subunit p65 was upregulated in the diabetic apoE-/- aorta. By contrast, diabetes-associated upregulation of NF-kappaB and subsequent NF-kappaB-dependent expression of proinflammatory genes were attenuated in diabetic RAGE-/-/apoE-/- mice. To complement the finding with respect to NF-kappaB, we measured gene expression of the NF-kappaB-dependent protein, MCP-1. MCP-1 gene expression was increased at least sixfold in the diabetic apoE-/- mice, and this increase was significantly attenuated in the RAGE-/-/apoE-/- mice in association with reduced macrophage infiltration.
###end p 49
###begin p 50
###xml 98 101 98 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 341 342 341 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 384 387 384 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 556 561 556 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP-9</italic>
###xml 624 627 624 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 698 703 698 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP-9</italic>
###xml 729 730 729 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 762 767 762 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP-9</italic>
###xml 804 807 804 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 812 815 812 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 880 881 880 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
###xml 628 632 <span type="species:ncbi:10090">mice</span>
###xml 816 820 <span type="species:ncbi:10090">mice</span>
In the present study, increased gene expression of various collagens was observed in diabetic apoE-/- mice. This result complements previous findings by several groups, including our own by demonstrating increased matrix accumulation as assessed by picrosirius red or increased collagen protein expression as assessed immunohistochemically (9,14). RAGE deletion in these diabetic apoE-/- mice particularly influenced collagen III gene expression, a finding similar to that seen previously with two chemically disparate AGE inhibitors (14). With respect to MMP-9 expression, the increase in mRNA levels in these diabetic apoE-/- mice complements findings by another group that specifically examined MMP-9 expression and activity (9). Furthermore, the decrease in MMP-9 expression seen in the diabetic RAGE-/-/apoE-/- mice is similar to that seen previously in studies using sRAGE (9). Previously, it has been suggested that the changes observed with respect to matrix and MMP expression in response to inhibition of RAGE may reflect stabilization of the plaque. Nevertheless, the long-term implications of the changes in MMPs and collagens seen in this model remain controversial because this is not considered a model of plaque rupture.
###end p 50
###begin p 51
###xml 57 60 57 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 65 68 65 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 210 211 210 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 400 403 400 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 408 411 408 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 665 668 665 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 721 724 721 724 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 729 732 729 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 901 904 901 904 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 909 912 909 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1055 1058 1055 1058 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1063 1066 1063 1066 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1388 1390 1388 1390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
###xml 669 673 <span type="species:ncbi:10090">mice</span>
###xml 749 753 <span type="species:ncbi:10090">mice</span>
###xml 858 862 <span type="species:ncbi:10090">mice</span>
###xml 913 917 <span type="species:ncbi:10090">mice</span>
###xml 995 999 <span type="species:ncbi:10090">mice</span>
###xml 1067 1071 <span type="species:ncbi:10090">mice</span>
The clear vasculoprotection observed in the diabetic RAGE-/-/apoE-/- mice further support previous experimental studies showing that blockade of RAGE activation, either with neutralizing antibodies or sRAGE (8,9,12), prevents the initiation and progression of atheroma formation in diabetic mice. It is noteworthy that in our study, both full-length and truncated isoforms of RAGE were absent in RAGE-/-/apoE-/- mice. Because RAGE has been reported to not only bind to AGEs but also to other ligands such as HMGB1 and certain S100 isoforms, these ligands were examined in this study. S100 A8/9 levels were increased in the plasma and aortic tissues in diabetic apoE-/- mice, and this increase was not observed in the RAGE-/-/apoE-/- double knockout mice, even in the presence of concomitant diabetes. A similar upregulation of HMGB1 in the aorta of diabetic mice was also not seen in vessels from RAGE-/-/apoE-/- mice. However, the circulating levels of HMGB1 were higher in the double knockout mice. This finding is unexplained but may occur because RAGE-/-/apoE-/- mice have no sRAGE to bind HMBG from the circulation, thus enhancing accumulation of this protein within the plasma. These findings extend recent in vitro studies, albeit in a nondiabetic context, describing effects of various RAGE ligands on chemokines, adhesion molecules, and MMPs, including MCP-1, VCAM-1, and MMP-2 (23).
###end p 51
###begin p 52
###xml 404 407 404 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 412 415 412 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
The finding that atherosclerosis was attenuated even in the absence of potentially protective circulating sRAGE strongly supports the postulate that the major mechanism of action of sRAGE is local antagonism of RAGE-dependent signaling. The importance of the full-length RAGE receptor in inflammatory vascular injury, even in the nondiabetic context, is suggested by the finding that even in control RAGE-/-/apoE-/- mice, there was reduced plaque accumulation, as was recently reported by another group (23).
###end p 52
###begin p 53
###xml 204 207 204 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 212 215 212 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
In summary, this study demonstrates that accelerated atherosclerotic plaque accumulation associated with diabetes is prevented in the absence of RAGE. The antiatherosclerotic effects seen in diabetic RAGE-/-/apoE-/- mice were associated with reduced expression of a range of proatherogenic factors, including ROS and inflammatory cytokines, ultimately leading to reduced leukocyte recruitment. Thus, these data provide further support for the development of novel therapies that target RAGE activation in the prevention and treatment of diabetic macrovascular complications.
###end p 53
###begin title 54
Supplementary Material
###end title 54
###begin title 55
Online-Only Appendix
###end title 55
###begin p 56
A.S.-P. has received grants from the Academy of Finland, the Orion-Farmos Research Foundation, and the Finnish Cardiovascular Research Foundation. A.K. has received support from Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (France). M.T. has received grants from the Juvenile Diabetes Research Foundation (JDRF) Center, NHMRC, National Health Fund (NHF), and the National Institutes of Health (5R0-HL-083452-02); a Career Development Award (NHMRC/Diabetes Australia); and the Kidney Health Australia-Bootle bequest. J.M.F. has received grants from the JDRF Center, NHMRC, NHF, and the National Institutes of Health (5R0-HL-083452-02) and is a recipient of a JDRF career development award. P.P.N. has received grants from the JDRF Center and the Deutsche Forschungs-gemeinschaft (SFB405). A.B. has received a JDRF Center grant. M.E.C. has received grants from the JDRF Center, NHMRC, NHF, and the National Institutes of Health (5R0-HL-083452-02). K.A.J.-D. has received grants from the JDRF Center, NHMRC, NHF, and the National Institutes of Health (5R0-HL-083452-02) and is a recipient of a NHMRC/NHF career development award.
###end p 56
###begin p 57
We thank Maryann Arnstein for excellent technical assistance and Kylie Gilbert and Steve Risis for their expertise in caring for the animals for the duration of the study.
###end p 57
###begin title 58
REFERENCES
###end title 58
###begin p 59
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 108 109 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 125 126 125 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 145 146 145 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 170 171 170 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 175 176 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 200 203 200 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 211 212 206 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 237 240 232 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 255 256 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 280 283 263 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 288 291 271 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 293 294 276 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 355 358 338 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 360 361 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 377 380 360 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 382 383 365 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 398 401 381 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 406 409 389 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 411 412 394 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 432 435 415 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 440 443 423 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 445 446 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
A: Quantitation of atherosclerotic plaque area (%) of aortic segments by the en face method in total aorta (a), aortic arch (b), thoracic aorta (c), and abdominal aorta (d). *P < 0.01 vs. control apoE-/-, daggerP < 0.01 vs. diabetic apoE-/-, double daggerP < 0.05 vs. control RAGE-/-/apoE-/-. B: Representative photomicrographs of aortas from control apoE-/- (a), diabetic apoE-/- (b), control RAGE-/-/apoE-/- (c), and diabetic RAGE-/-/apoE-/- (d) using the en face technique. Lesions are shown in red after Sudan IV staining. (Please see  for a high-quality digital representation of this figure.)
###end p 59
###begin p 60
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 109 112 109 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 114 115 114 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 131 134 131 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 136 137 136 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 152 155 152 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 160 163 160 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 165 166 165 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 186 189 186 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 194 197 194 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 199 200 199 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 228 229 227 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 300 301 299 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 325 328 324 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 336 337 330 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 363 366 357 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 381 382 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 406 409 388 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 414 417 396 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 431 432 402 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 457 460 428 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 485 486 454 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 590 593 559 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 595 596 564 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 612 615 581 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 617 618 586 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 633 636 602 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 641 644 610 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 651 652 620 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 672 675 641 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 680 683 649 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 685 686 654 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 709 710 677 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 783 784 751 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 809 812 777 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 820 821 783 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 846 849 809 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 864 865 815 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 889 892 840 843 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 897 900 848 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 645 649 <span type="species:ncbi:10090">mice</span>
A: Representative aortic sections showing anti-CD3 staining demonstrating T-cell accumulation in control apoE-/- (a), diabetic apoE-/- (b), control RAGE-/-/apoE-/- (c), and diabetic RAGE-/-/apoE-/- (d) mice. Scale bar = 20 mum. B: Graph presenting percentage of CD3-positive staining in each group. *P < 0.05 vs. control apoE-/-, daggerP < 0.001 vs. diabetic apoE-/-, double daggerP < 0.05 vs. control RAGE-/-/apoE-/-. section signP < 0.001 vs. control apoE-/-. Data are means +/- SE. C: Representative aortic sections of F4/80 staining demonstrating macrophage infiltration in control apoE-/- (a), diabetic apoE-/- (b), control RAGE-/-/apoE-/- mice (c), and diabetic RAGE-/-/apoE-/- (d). Scale bar = 20 mum. D: Graph presenting percentage of F4/80-positive staining in each group. *P < 0.001 vs. control apoE-/-, daggerP < 0.01 vs. diabetic apoE-/-, double daggerP < 0.05 vs. control RAGE-/-/apoE-/-. Data are means +/- SE. (Please see  for a high-quality digital representation of this figure.)
###end p 60
###begin p 61
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 91 94 91 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 140 143 140 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 145 146 145 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 162 165 162 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 167 168 167 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 183 186 183 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 191 194 191 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 196 197 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 217 220 217 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 225 228 225 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 230 231 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 259 260 258 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 334 335 333 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 360 363 359 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 371 372 365 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 397 400 391 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 415 416 397 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 441 444 423 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
A: Representative aortic sections demonstrating increased CML staining in the diabetic apoE-/- aorta. Panel presents aorta from control apoE-/- (a), diabetic apoE-/- (b), control RAGE-/-/apoE-/- (c), and diabetic RAGE-/-/apoE-/- (d) mice. Scale bar = 20 mum. B: Graph presenting percentage of CML-positive aortic area in each group. *P < 0.001 vs. control apoE-/-, daggerP < 0.01 vs. diabetic apoE-/-, double daggerP < 0.05 vs. diabetic apoE-/-. Data are means +/- SE. (Please see  for a high-quality digital representation of this figure.)
###end p 61
###begin p 62
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 78 81 78 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 83 84 83 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 100 103 100 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 105 106 105 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 121 124 121 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 129 132 129 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 134 135 134 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 155 158 155 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 163 166 163 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 168 169 168 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 197 198 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 274 275 273 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 299 302 298 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 310 311 304 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 336 339 330 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
A: Representative aortic sections demonstrating HMGB1 staining in control apoE-/- (a), diabetic apoE-/- (b), control RAGE-/-/apoE-/- (c), and diabetic RAGE-/-/apoE-/- (d) mice. Scale bar = 20 mum. B: Graph presenting percentage of HMGB1-positive aortic area in each group. *P < 0.05 vs. control apoE-/-, daggerP < 0.05 vs. diabetic apoE-/-. Data are expressed as means +/- SE. (Please see  for a high-quality digital representation of this figure.)
###end p 62
###begin p 63
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 197 200 197 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 284 287 284 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 289 290 289 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 306 309 306 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 311 312 311 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 327 330 327 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 335 338 335 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 340 341 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 361 364 361 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 369 372 369 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 374 375 374 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 403 404 402 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 484 485 483 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 509 512 508 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 520 521 514 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 546 549 540 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 551 552 545 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 611 614 605 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 646 649 640 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 658 661 652 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 666 669 660 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 672 673 666 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 697 700 691 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 708 709 697 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 735 738 724 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 615 619 <span type="species:ncbi:10090">mice</span>
A: Representative histological sections demonstrating increased S100A8/A9 staining, particularly in foam cells, endothelial cells (see arrow) and macrophages (see double arrow) in the diabetic apoE-/- aorta. Panel presents photomicrographs from aortic wall and plaques in control apoE-/- (a), diabetic apoE-/- (b), control RAGE-/-/apoE-/- (c), and diabetic RAGE-/-/apoE-/- (d) mice. Scale bar = 20 mum. B: Graph presenting percentage of S100A8/A9-positive aortic area in each group. *P < 0.05 vs. control apoE-/-, daggerP < 0.01 vs. diabetic apoE-/-. C: Plasma levels of S100A8/A9 are increased in diabetic apoE-/- mice compared with control apoE-/- and RAGE-/-/apoE-/-. *P < 0.01 vs. control apoE-/-, daggerP < 0.001 vs. diabetic apoE-/-. Data are means +/- SE. (Please see  for a high-quality digital representation of this figure.)
###end p 63
###begin p 64
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 56 59 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 185 188 185 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 190 191 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 207 210 207 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 212 213 212 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 228 231 228 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 236 239 236 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 241 242 241 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 262 265 262 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 270 273 270 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 275 276 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 304 305 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 389 390 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 414 417 413 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 425 426 419 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 451 454 445 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
A: Nitrotyrosine expression is enhanced in diabetic apoE-/- aorta indicative of increased oxidative stress. Representative aortic sections showing nitrotyrosine staining in control apoE-/- (a), diabetic apoE-/- (b), control RAGE-/-/apoE-/- (c), and diabetic RAGE-/-/apoE-/- (d) mice. Scale bar = 20 mum. B: Graph presenting percentage of nitrotyrosine-positive aortic area in each group. *P < 0.05 vs. control apoE-/-, daggerP < 0.05 vs. diabetic apoE-/-. Data are means +/- SE. (Please see  for a high-quality digital representation of this figure.)
###end p 64
###begin p 65
Metabolic parameters of the groups at week 20
###end p 65
###begin p 66
Data are means +/- SE.
###end p 66
###begin p 67
GHb and weight measurements performed in 24 animals/group.
###end p 67
###begin p 68
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 26 29 26 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
P < 0.001 vs. control apoE-/- group;
###end p 68
###begin p 69
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 26 29 26 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
P < 0.05 vs. diabetic apoE-/- group;
###end p 69
###begin p 70
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 33 36 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
P < 0.05 vs. control RAGE-/-/apoE-/-.
###end p 70
###begin p 71
Gene expression of proatherogenic mediators in the aorta
###end p 71
###begin p 72
Data are means +/- SE.
###end p 72
###begin p 73
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
P < 0.05 vs. control apoE-/- group;
###end p 73
###begin p 74
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 26 29 26 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
P < 0.05 vs. diabetic apoE-/- group;
###end p 74
###begin p 75
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 33 36 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
P < 0.05 vs. control RAGE-/-/apoE-/-.
###end p 75

